APO M250 (Mycophenolate Mofetil 250 mg)
Pill with imprint APO M250 is Blue & Pink, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Apotex Corp..
Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO M250
- APO M250
- 250 mg
- Blue & Pink
- 19.00 mm
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- Inactive Ingredients
sodium lauryl sulfate,
ferric oxide red,
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|60505-2968 (Discontinued)||Apotex Corp.|
|68084-0587 (Discontinued)||Amerisource Health Services|
Related Images for "APO M250"
More about mycophenolate mofetil
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 52 Reviews
- Drug class: selective immunosuppressants
- Drug Information
- Mycophenolate Intravenous (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
- Other brands
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.